Published in Arch Gen Psychiatry on June 01, 1991
Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci (2008) 1.85
"Getting physical": the management of neuropsychiatric disorders using novel physical treatments. Neuropsychiatr Dis Treat (2006) 0.92
Pediatric indications for deep brain stimulation. Childs Nerv Syst (2012) 0.85
Neuromodulation for obsessive-compulsive disorder. Neurotherapeutics (2014) 0.83
Functional neurosurgery in the treatment of severe obsessive compulsive disorder and major depression: overview of disease circuits and therapeutic targeting for the clinician. Psychiatry (Edgmont) (2008) 0.80
Nucleus accumbens core and pathogenesis of compulsive checking. Behav Pharmacol (2015) 0.77
Nonpharmacological treatments for anxiety disorders. Dialogues Clin Neurosci (2002) 0.76
Deep brain stimulation for the treatment of severe, medically refractory obsessive-compulsive disorder. Perm J (2013) 0.75
Psychosurgical treatment of obsessive-compulsive disorder. Arch Gen Psychiatry (1992) 0.75
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Ther (2000) 4.33
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg (1985) 3.73
Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature (1986) 3.40
Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med (1995) 3.37
The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry (1998) 3.26
Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry (1994) 2.70
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions. Nat Med (2001) 2.64
The coronary-care unit. An appraisal of its psychologic hazards. N Engl J Med (1968) 2.43
Factors contributing to delay in responding to the signs and symptoms of acute myocardial infarction. Am J Cardiol (1969) 2.36
Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature (1987) 2.32
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am J Psychiatry (1990) 2.22
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science (1987) 2.06
Patient delay in cancer. N Engl J Med (1973) 2.05
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry (1999) 2.03
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc Natl Acad Sci U S A (2001) 1.99
The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. development and factor analyses. Psychother Psychosom (1995) 1.92
Self-injurious skin picking: clinical characteristics and comorbidity. J Clin Psychiatry (1999) 1.87
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. Hum Gene Ther (1999) 1.84
An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. N Engl J Med (1991) 1.79
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry (1995) 1.71
Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A (1987) 1.63
Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry (1996) 1.56
Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry (1997) 1.47
Bowel obsessions responsive to tricyclic antidepressants in four patients. Am J Psychiatry (1987) 1.44
Open trial of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry (1989) 1.44
Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus. Hum Gene Ther (1999) 1.43
Act locally, think globally. Nat Med (1997) 1.43
The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest (1970) 1.42
Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res (1994) 1.41
Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery (1993) 1.39
Bilateral acoustic neuromas: clinical aspects, pathogenesis, and treatment. Neurosurgery (1982) 1.34
Repetitive skin-picking in a student population and comparison with a sample of self-injurious skin-pickers. Psychosomatics (2000) 1.32
Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc (2000) 1.30
Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg (1992) 1.28
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates. J Virol (1999) 1.26
Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg (1991) 1.25
The relationship between semantic organization and memory in obsessive-compulsive disorder. Psychother Psychosom (2000) 1.23
Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry (2000) 1.22
Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol (1991) 1.22
Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1. Cancer Res (1995) 1.22
Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder. Biol Psychiatry (1999) 1.22
Intravascular clotting and acute pancreatitis in primary hyperparathyroidism. Ann Intern Med (1966) 1.21
A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry (1995) 1.20
Hypertension is associated with severe erectile dysfunction. J Urol (2000) 1.19
The Massachusetts General Hospital (MGH) Hairpulling Scale: 2. reliability and validity. Psychother Psychosom (1995) 1.16
Sensitivity of the six-item Hamilton Depression Rating Scale. Acta Psychiatr Scand (1997) 1.15
Mechanisms of renal lithium handling and their relationship to mineralocorticoids: a dissociation between sodium and lithium ions. J Psychiatr Res (1971) 1.14
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Oncogene (2001) 1.13
In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity. J Immunol (1998) 1.13
Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207. Hum Gene Ther (1999) 1.13
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma. Neoplasia (1999) 1.13
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. Am J Cardiol (1973) 1.13
Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol (1990) 1.13
Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain. Gene Ther (2005) 1.13
Preservation of hearing and facial nerve function in resection of acoustic neuroma. Laryngoscope (1992) 1.12
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers. Cancer Gene Ther (2006) 1.11
Statistical problems with small sample size. Am J Psychiatry (1993) 1.10
Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res (1990) 1.10
Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry (1997) 1.09
Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus. Mol Ther (2000) 1.08
Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res (1992) 1.08
Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. Hum Gene Ther (1998) 1.07
Neurofibromatosis type 2 appears to be a genetically homogeneous disease. Am J Hum Genet (1992) 1.07
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice. J Virol (2000) 1.05
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. Am J Cardiol (1973) 1.05
Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. Am J Med (1973) 1.05
Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am J Hum Genet (1990) 1.04
Strategic processing and episodic memory impairment in obsessive compulsive disorder. Neuropsychology (2000) 1.04
Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas. J Neurosurg (1985) 1.04
Transcriptional targeting of herpes simplex virus for cell-specific replication. J Virol (1997) 1.03
Development of a quantitative rating scale to assess denial. J Psychosom Res (1974) 1.03
The Skin Picking Scale: scale construction and psychometric analyses. J Psychosom Res (2001) 1.03
Cardiac failure in Addison's disease. Am J Med (1983) 1.03
Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry (1997) 1.03
AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo. Neurosurgery (1994) 1.02
Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry (1995) 1.02
Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol (1983) 1.02
Preservation of hearing in surgical removal of acoustic neuromas of the internal auditory canal and cerebellar pontine angle. Laryngoscope (1987) 1.02
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells. Cancer Gene Ther (2009) 1.01
Psychiatric consultation in a coronary care unit. Ann Intern Med (1971) 1.01
Self-administered psychotherapy for depression using a telephone-accessed computer system plus booklets: an open U.S.-U.K. study. J Clin Psychiatry (1998) 1.01
Psychological rehabilitation of myocardial infarction patients in the acute phase. Heart Lung (1973) 1.00
Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Natl Acad Sci U S A (1989) 0.99
Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates. Hum Gene Ther (2001) 0.98
Laser-induced fluorescence: experimental intraoperative delineation of tumor resection margins. J Neurosurg (1992) 0.97
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry (2001) 0.97
The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension. Am J Med (1975) 0.97
Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg (1985) 0.97
Confronting the decision to let death come. Crit Care Med (1974) 0.97
Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis (1998) 0.97
A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia. Psychosomatics (1990) 0.96
Longitudinal follow-up of naturalistic treatment outcome in patients with trichotillomania. J Clin Psychiatry (2001) 0.94
Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: a quantitative review. Behav Res Ther (1996) 0.94
Specific estradiol binding in schwannomas, meningiomas, and neurofibromas. Neurosurgery (1981) 0.94